Conmed Stock Technical Analysis
| CNMD Stock | USD 38.39 1.08 2.89% |
As of the 31st of January, CONMED shows the risk adjusted performance of (0.07), and Mean Deviation of 1.86. CONMED technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CONMED variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if CONMED is priced favorably, providing market reflects its regular price of 38.39 per share. Given that CONMED has information ratio of (0.13), we suggest you to validate CONMED's prevailing market performance to make sure the company can sustain itself in the future.
CONMED Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as CONMED, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CONMEDCONMED's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.CONMED Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 48.6 | Buy | 6 | Odds |
Most CONMED analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CONMED stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CONMED, talking to its executives and customers, or listening to CONMED conference calls.
Will Health Care Equipment & Supplies sector continue expanding? Could CONMED diversify its offerings? Factors like these will boost the valuation of CONMED. Projected growth potential of CONMED fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CONMED data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.50) | Dividend Share 0.6 | Earnings Share 1.55 | Revenue Per Share | Quarterly Revenue Growth 0.079 |
CONMED's market price often diverges from its book value, the accounting figure shown on CONMED's balance sheet. Smart investors calculate CONMED's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CONMED's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between CONMED's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CONMED should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CONMED 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CONMED's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CONMED.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in CONMED on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding CONMED or generate 0.0% return on investment in CONMED over 90 days. CONMED is related to or competes with Establishment Labs, Adapthealth Corp, UFP Technologies, SS Innovations, Neogen, InMode, and Kestra Medical. CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipme... More
CONMED Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CONMED's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CONMED upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 14.72 | |||
| Value At Risk | (3.89) | |||
| Potential Upside | 3.36 |
CONMED Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CONMED's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CONMED's standard deviation. In reality, there are many statistical measures that can use CONMED historical prices to predict the future CONMED's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.42) | |||
| Treynor Ratio | (0.38) |
CONMED January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.37) | |||
| Mean Deviation | 1.86 | |||
| Coefficient Of Variation | (888.36) | |||
| Standard Deviation | 2.54 | |||
| Variance | 6.43 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.42) | |||
| Treynor Ratio | (0.38) | |||
| Maximum Drawdown | 14.72 | |||
| Value At Risk | (3.89) | |||
| Potential Upside | 3.36 | |||
| Skewness | (0.95) | |||
| Kurtosis | 2.42 |
CONMED Backtested Returns
CONMED secures Sharpe Ratio (or Efficiency) of -0.0864, which signifies that the company had a -0.0864 % return per unit of risk over the last 3 months. CONMED exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CONMED's mean deviation of 1.86, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.77, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CONMED's returns are expected to increase less than the market. However, during the bear market, the loss of holding CONMED is expected to be smaller as well. At this point, CONMED has a negative expected return of -0.22%. Please make sure to confirm CONMED's maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if CONMED performance from the past will be repeated in the future.
Auto-correlation | 0.17 |
Very weak predictability
CONMED has very weak predictability. Overlapping area represents the amount of predictability between CONMED time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CONMED price movement. The serial correlation of 0.17 indicates that over 17.0% of current CONMED price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 2.6 |
CONMED technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
CONMED Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of CONMED volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About CONMED Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of CONMED on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of CONMED based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on CONMED price pattern first instead of the macroeconomic environment surrounding CONMED. By analyzing CONMED's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of CONMED's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to CONMED specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.007296 | 0.0117 | 0.0148 | 0.0138 | Price To Sales Ratio | 2.7 | 1.62 | 0.92 | 0.98 |
CONMED January 31, 2026 Technical Indicators
Most technical analysis of CONMED help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CONMED from various momentum indicators to cycle indicators. When you analyze CONMED charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.37) | |||
| Mean Deviation | 1.86 | |||
| Coefficient Of Variation | (888.36) | |||
| Standard Deviation | 2.54 | |||
| Variance | 6.43 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.42) | |||
| Treynor Ratio | (0.38) | |||
| Maximum Drawdown | 14.72 | |||
| Value At Risk | (3.89) | |||
| Potential Upside | 3.36 | |||
| Skewness | (0.95) | |||
| Kurtosis | 2.42 |
CONMED January 31, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as CONMED stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.05 | ||
| Daily Balance Of Power | 0.54 | ||
| Rate Of Daily Change | 1.03 | ||
| Day Median Price | 37.45 | ||
| Day Typical Price | 37.76 | ||
| Price Action Indicator | 1.48 | ||
| Market Facilitation Index | 2.01 |
Complementary Tools for CONMED Stock analysis
When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |